Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
10. September 2024 • News
10. September 2024 • News
The Saxon-Thuringian robotics start-up TEDIRO will receive a seven-figure sum in funding. The company is developing a gait training robot to help restore patient mobility and relieve care staff.
The Saxon-Thuringian start-up TEDIRO Healthcare Robotics GmbH is receiving a seven-figure sum of funding from bm|t and TGFS Technologiegründerfonds Sachsen. Other investors include a business angel and the robotics manufacturer MetraLabs GmbH Neue Technologien und Systeme, from which TEDIRO was spun off. The award-winning company is in the process of developing the world’s first mobile robot that uses camera-based motion capture and AI technology for gait training. TEDIRO plans to use the funds to carry out tests in clinics and launch the robot as a medical product in the near future.
The idea for the robot, called THERY, was developed at one of Germany’s largest orthopedic clinics in collaboration with Jena University Hospital, Ilmenau University of Technology, and MetraLabs. THERY accompanies mobility-impaired patients while they are on crutches, with the goal of maintaining or restoring mobility. In the process, the robot can take some of the pressure off of medical and therapeutic personnel, who are often short-staffed. In the future, TEDIRO’s robotics experts and software developers want to develop the robot further to cover a variety of other applications, including in orthopedics, neurology and geriatrics.
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
The European Commission has approved the Saxon ERDF/JTF program for the funding period 2021 to 2027.